spacer
home > ebr > autumn 2017 > adapt to survive
PUBLICATIONS
European Biopharmaceutical Review

Adapt to Survive

No market is immune to change, and life sciences continues to face its fair share of upheaval as the industry accommodates emerging innovation in healthcare and a raft of other challenges to the status quo. Below are five of the most prominent trends and what they mean in practice.

Strategic Acquisitions

As a shortcut to attractive new product lines, when development and testing cycles can be frustratingly long, companies are increasingly sizing up strategic purchases. 2016 saw high levels of merger and acquisition (M&A) activity and more of the same had been forecast for 2017 (1,2). Though this has not quite materialised so far, it is expected to pick up in the second half of the year.

However, profiting from these deals means the acquiring company must be able to align its branding, content and labelling quickly, reliably and efficiently. This is essential in upholding brand image, stabilising compliance efforts and maximising process efficiency, as well as market opportunity.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
1
     

There are no comments in regards to this article.

spacer
Peter Muller is Managing Director for Schlafender Hase, Americas. For the last 20 years, he has worked on software and process improvement projects with Fortune 500 companies from various industries including pharma, consumer goods, food, aerospace and defence. Peter has a wealth of experience working with international clients to define their organisationsí goals and help them leverage new technologies to achieve productivity gains, process improvements and cost savings.
spacer
Peter Muller
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Laboratory Gains ISO 17025 Accreditation for Transit Simulation

Medical Engineering Technologiesí packaging laboratory now has ISTA 2A and ASTM D4169 transit testing added to its accreditation.
More info >>

White Papers

Keeping Abreast of the Competitive Environment in Clinical Development

Thomson Reuters

Strategic management of a therapy area requires hard decisions to be made about which programs to invest in and which to let go. Understanding the rapidly changing competitive environment for your drug candidates is a key input into these decisions. It is easy to lose track of the broader picture when a clinical program is in progress and get blindsided by external events.
More info >>

 
Industry Events

Cell Therapy Manufacturing & Gene Therapy Congress

4-6 December 2018, RAI, Amsterdam

Bringing together 300+ leaders and key influencers from pharma and biotech companies on 4 - 6 December 2018 in Amsterdam, Cell Therapy Manufacturing & Gene Therapy will provide you with the latest advice for transforming innovative research to prosperous cell & gene therapy manufacturing.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement